BETRNet seminars, 2014–2021
|
2014 |
|
||||
|
July |
John M. Inadomi, MD University of Michigan |
CISNET esophagus group and the ongoing collaborative computer modeling analysis being conducted |
|
||
|
Prasad G. Iyer, MD Mayo Clinic |
Comparative effectiveness of screening for Barrett’s esophagus: Results from a randomized controlled trial |
|
|||
|
September |
Thomas L. Vaughan, MD, MPH Fred Hutchinson Cancer Research Center |
BEACON consortium: Update and collaborative opportunities |
|
||
|
November |
Antonia Sepulveda, MD, PhD Columbia University |
Genomic testing for dysplasia and adenocarcinoma risk stratification of Barrett’s esophagus patients |
|
||
|
Vinay Varadan, PhD Case Western Reserve University |
Decoding the EAC transcriptome |
|
|||
|
2015 |
|||||
|
March |
Rhonda Souza, PhD Baylor University |
The role of refluxed acid and bile in Barrett’s metaplasia and its progression to cancer |
|
||
|
July |
David Beer, PhD University of Michigan |
OPN and integrin signaling in esophageal adenocarcinoma |
|
||
|
2016-2017 (hiatus) |
|
||||
|
2018 |
|
||||
|
January |
Abbes Belkhiri, PhD Vanderbilt University |
AXL-mediated upregulation of c-MYC expression promotes epirubicin resistance in esophageal adenocarcinoma |
|
||
|
March |
David Beer, PhD & Dipankar Ray, PhD University of Michigan |
RNF128 regulation of TP53 in Barrett’s progression |
|
||
|
May |
Yiping Han, PhD Columbia University |
Fusobacterium nucleatum in colorectal and esophageal adenocarcinomas |
|
||
|
July |
Vinay Varadan, PhD Case Western Reserve University |
Multi-scale integrative analytics to decode complex disease mechanisms |
|
||
|
September |
Kelly Whelan, PhD Temple University |
Mechanisms of esophageal homeostasis: Implications for improving patient outcomes in food allergy and cancer |
|
||
|
2019 |
|
||||
|
January |
Kevin Kang, PhD Florida Atlantic University |
Engineering 3D tumor tissue model for esophageal cancer |
|
||
|
March |
Hiroshi Nakagawa, MD, PhD Columbia University |
Esophageal 3D organoids: Insights into pathobiology and precision medicine |
|
||
|
2020 |
|
||||
|
March |
Derek Nancarrow, PhD University of Michigan |
Engineering 3D tumor tissue model for esophageal cancer |
|
||
|
May |
Wael El-Rifai, MD, PhD University of Miami |
The Jekyll & Hyde of antioxidant response in Barrett’s carcinogenesis |
|
||
|
September |
Georg Luebeck, PhD Fred Hutchinson Cancer Research Center |
Mathematical modeling of EAC incidence patterns: What do they tell us about secular trends in BE incidence? |
|
||
|
2021 |
|
||||
|
March |
Ricardo Cruz-Acuña, PhD Columbia University |
Engineered hydrogel to elucidate contributions of matrix mechanics to esophageal adenocarcinoma and identify matrix-activated therapeutic targets |
|
||
|
May |
Xiaoxin “Luke” Chen, PhD University of North Carolina |
Targeted therapy for NRF2high esophageal squamous cell carcinoma |
|
||
|
July |
Dipankar Ray, PhD University of Michigan |
Understanding the RNF128 Iso1 and mutant p53 cooperation in Barrett’s progression |
|
||
|
November |
Kiran Lagisetty, MD University of Michigan |
Immune determinants of Barrett's progression to esophageal adenocarcinoma |
|
||